|
1
|
American Cancer Society. Lung Cancer
(Non-Small Cell). http://www.cancer.org/cancer/lungcancer-non-smallcell/detaile-dguide/non-small-cell-lung-cancer-key-statistics.
Accessed August 16, 2013
|
|
2
|
Geutjes EJ, Bajpe PK and Bernards R:
Targeting the epigenome for treatment of cancer. Oncogene.
31:3827–3844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zöchbauer-Müller S, Fong KM, Virmani AK,
Geradts J, Gazdar AF and Minna JD: Aberrant promoter methylation of
multiple genes in non-small cell lung cancers. Cancer Res.
61:249–255. 2001.PubMed/NCBI
|
|
4
|
Hur K, Cejas P, Feliu J, et al:
Hypomethylation of long interspersed nuclear element-1 (LINE-1)
leads to activation of proto-oncogenes in human colorectal cancer
metastasis. Gut. 63:635–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jung KH, Noh JH, Kim JK, et al: HDAC2
overexpression confers oncogenic potential to human lung cancer
cells by deregulating expression of apoptosis and cell cycle
proteins. J Cell Biochem. 113:2167–2177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayashi A, Horiuchi A, Kikuchi N, et al:
Type-specific roles of histone deacetylase (HDAC) overexpression in
ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3
stimulates cell migration with downregulation of E-cadherin. Int J
Cancer. 127:1332–1346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lujambio A and Esteller M: How epigenetics
can explain human metastasis: a new role for microRNAs. Cell Cycle.
8:377–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He L, Thomson JM, Hemann MT, et al: A
microRNA polycistron as a potential human oncogene. Nature.
435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song SJ, Ito K, Ala U, et al: The
oncogenic microRNA miR-22 targets the TET2 tumor suppressor to
promote hematopoietic stem cell self-renewal and transformation.
Cell Stem Cell. 13:87–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen P, Price C, Li Z, et al: miR-9 is an
essential oncogenic microRNA specifically overexpressed in mixed
lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA.
110:11511–11516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin
LR: MicroRNA-503 suppresses proliferation and cell-cycle
progression of endometrioid endometrial cancer by negatively
regulating cyclin D1. FEBS J. 280:3768–3779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhodes LV, Nitschke AM, Segar HC, et al:
The histone deacetylase inhibitor trichostatin A alters microRNA
expression profiles in apoptosis-resistant breast cancer cells.
Oncol Rep. 27:10–16. 2012.
|
|
16
|
Scott GK, Mattie MD, Berger CE, Benz SC
and Benz CC: Rapid alteration of microRNA levels by histone
deacetylase inhibition. Cancer Res. 66:1277–1281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chatterjee N, Wang WL, Conklin T, Chittur
S and Tenniswood M: Histone deacetylase inhibitors modulate miRNA
and mRNA expression, block metaphase and induce apoptosis in
inflammatory breast cancer cells. Cancer Biol Ther. 14:658–671.
2013. View Article : Google Scholar
|
|
18
|
Bandres E, Agirre X, Bitarte N, et al:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee EM, Shin S, Cha HJ, et al:
Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression
profiles in A549 human non-small cell lung cancer cells. Int J Mol
Med. 24:45–50. 2009.PubMed/NCBI
|
|
21
|
Heller G, Weinzierl M, Noll C, et al:
Genome-wide miRNA expression profiling identifies miR-9–3 and
miR-193a as targets for DNA methylation in non-small cell lung
cancers. Clin Cancer Res. 18:1619–1629. 2012.
|
|
22
|
Rice JC, Briggs SD, Ueberheide B, et al:
Histone methyltransferases direct different degrees of methylation
to define distinct chromatin domains. Mol Cell. 12:1591–1598. 2003.
View Article : Google Scholar
|
|
23
|
Tachibana M, Sugimoto K, Nozaki M, et al:
G9a histone methyltransferase plays a dominant role in euchromatic
histone H3 lysine 9 methylation and is essential for early
embryogenesis. Genes Dev. 16:1779–1791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang J, Dorsey J, Chuikov S, et al: G9a
and Glp methylate lysine 373 in the tumor suppressor p53. J Biol
Chem. 285:9636–9641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kondo Y, Shen L, Suzuki S, et al:
Alterations of DNA methylation and histone modifications contribute
to gene silencing in hepatocellular carcinomas. Hepatol Res.
37:974–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nguyen CT, Weisenberger DJ, Velicescu M,
et al: Histone H3-lysine 9 methylation is associated with aberrant
gene silencing in cancer cells and is rapidly reversed by
5-aza-2′-deoxycytidine. Cancer Res. 62:6456–6461. 2002.PubMed/NCBI
|
|
27
|
McGarvey KM, Fahrner JA, Greene E, Martens
J, Jenuwein T and Baylin SB: Silenced tumor suppressor genes
reactivated by DNA demethylation do not return to a fully
euchromatic chromatin state. Cancer Res. 66:3541–3549. 2006.
View Article : Google Scholar
|
|
28
|
Chen MW, Hua KT, Kao HJ, et al: H3K9
histone methyltransferase G9a promotes lung cancer invasion and
metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer
Res. 70:7830–7840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kondo Y, Shen L, Ahmed S, et al:
Downregulation of histone H3 lysine 9 methyltransferase G9a induces
centrosome disruption and chromosome instability in cancer cells.
PLoS One. 3:e20372008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kubicek S, O’Sullivan RJ, August EM, et
al: Reversal of H3K9me2 by a small-molecule inhibitor for the G9a
histone methyltransferase. Mol Cell. 25:473–481. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu Z, Tian Y, Salwen HR, et al:
Histone-lysine methyltransferase EHMT2 is involved in
proliferation, apoptosis, cell invasion, and DNA methylation of
human neuroblastoma cells. Anticancer Drugs. 24:484–493. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X: miRDB: a microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X and El Naqa IM: Prediction of both
conserved and nonconserved microRNA targets in animals.
Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Duncan D, Shi Z and Zhang B:
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013.
Nucleic Acids Res. 41:W77–W83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Validation of miRNA Microarray Results
with Real-Time qPCR. Technical Bulletin. LC Sciences; Houston, TX,
USA:
|
|
36
|
Law FB, Chen YW, Wong KY, et al:
Identification of a novel tumor transforming gene GAEC1 at 7q22
which encodes a nuclear protein and is frequently amplified and
overexpressed in esophageal squamous cell carcinoma. Oncogene.
26:5877–5888. 2007. View Article : Google Scholar
|
|
37
|
Nagel S, Leich E, Quentmeier H, et al:
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell
lymphoma. Leukemia. 22:387–392. 2008. View Article : Google Scholar
|
|
38
|
Kwei KA, Shain AH, Bair R, et al: SMURF1
amplification promotes invasiveness in pancreatic cancer. PLoS One.
6:e239242011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mu D, Chen L, Zhang X, et al: Genomic
amplification and oncogenic properties of the KCNK9 potassium
channel gene. Cancer Cell. 3:297–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ho JC, Cheung ST, Patil M, Chen X and Fan
ST: Increased expression of glycosyl-phosphatidylinositol anchor
attachment protein 1 (GPAA1) is associated with gene amplification
in hepatocellular carcinoma. Int J Cancer. 119:1330–1337. 2006.
View Article : Google Scholar
|
|
41
|
Kan T, Sato F, Ito T, et al: The
miR-106b-25 polycistron, activated by genomic amplification,
functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 136:1689–1700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
John AS, Hu X, Rothman VL and Tuszynski
GP: Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of
metalloproteinase-1 (TIMP-1) production in human tumor cells:
exploring the functional significance in tumor cell invasion. Exp
Mol Pathol. 87:184–188. 2009. View Article : Google Scholar
|
|
44
|
Espejo R, Rengifo-Cam W, Schaller MD,
Evers BM and Sastry SK: PTP-PEST controls motility, adherens
junction assembly, and Rho GTPase activity in colon cancer cells.
Am J Physiol Cell Physiol. 299:C454–C463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tan KD, Zhu Y, Tan HK, et al:
Amplification and overexpression of PPFIA1, a putative 11q13
invasion suppressor gene, in head and neck squamous cell carcinoma.
Genes Chromosomes Cancer. 47:353–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou Q, Huang T, Wang YF, Zhang KS, Chen D
and Peng BG: Identification of Max binding protein as a novel
binding protein of Nck1 and characterization of its role in
inhibiting human liver cancer SK-HEP-1 cells. Chin Med J (Engl).
125:3336–3339. 2012.PubMed/NCBI
|
|
47
|
Penna E, Orso F, Cimino D, et al:
microRNA-214 contributes to melanoma tumour progression through
suppression of TFAP2C. EMBO J. 30:1990–2007. 2011. View Article : Google Scholar : PubMed/NCBI
|
